Metraipolis › archive › dc_5d9d5e5fedbc
Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia: a post hoc analysis of… — Europe PMC PMID:41929365
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41929365
- DOI
- 10.3389/fpsyt.2026.1751249
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T06:57:59.794Z
- SHA-256 of the archived text
d7d4bdb89aa18f55b0568eb91ec4961dabce64fc09f57a772ef9216fc4c1a8e6- Stable URL of this page
https://metraipolis.com/documento/dc_5d9d5e5fedbc
How to cite
Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia: a post hoc analysis of… — Europe PMC PMID:41929365 — Europe PMC (en), https://europepmc.org/article/MED/41929365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5d9d5e5fedbc (Metraipolis archive dc_5d9d5e5fedbc, sha256 d7d4bdb89aa18f55b0568eb91ec4961dabce64fc09f57a772ef9216fc4c1a8e6)
BibTeX
@misc{dc5d9d5e5fedbc,
title = {Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia: a post hoc analysis of… — Europe PMC PMID:41929365},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41929365},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5d9d5e5fedbc; sha256 d7d4bdb89aa18f55b0568eb91ec4961dabce64fc09f57a772ef9216fc4c1a8e6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41929365. Agents can read the archived copy with the MCP tool read_document.